Unresectable Sarcoma Completed Phase 1 Trials for Valproic acid (DB00313)

IndicationStatusPhase
DBCOND0047232 (Unresectable Sarcoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01106872Bevacizumab, Chemotherapy and Valproic Acid in Advanced SarcomasTreatment